Citations (238)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Keti Bardhi, Shelby Coates, Christy J.W. Watson & Philip Lazarus. (2022) Cannabinoids and drug metabolizing enzymes: potential for drug-drug interactions and implications for drug safety and efficacy. Expert Review of Clinical Pharmacology 15:12, pages 1443-1460.
Read now
Read now
Myfanwy Graham, Jennifer H Martin, Catherine J Lucas, Bridin Murnion & Jennifer Schneider. (2022) Cannabidiol drug interaction considerations for prescribers and pharmacists. Expert Review of Clinical Pharmacology 15:12, pages 1383-1397.
Read now
Read now
Nazeer Hasan, Mohammad Imran, Afsana Sheikh, Suma Saad, Gaurav Chaudhary, Gaurav Kumar Jain, Prashant Kesharwani & Farhan J. Ahmad. (2022) Cannabis as a potential compound against various malignancies, legal aspects, advancement by exploiting nanotechnology and clinical trials. Journal of Drug Targeting 30:7, pages 709-725.
Read now
Read now
Xin Zhou, Tian-Man Li, Jian-Zhu Luo, Chen-Lu Lan, Zhong-Liu Wei, Tian-Hao Fu, Xi-Wen Liao, Guang-Zhi Zhu, Xin-Ping Ye & Tao Peng. (2021) CYP2C8 Suppress Proliferation, Migration, Invasion and Sorafenib Resistance of Hepatocellular Carcinoma via PI3K/Akt/p27kip1 Axis. Journal of Hepatocellular Carcinoma 8, pages 1323-1338.
Read now
Read now
Bernhard Beitzke & David W. Pate. (2021) A broader view on deriving a reference dose for THC traces in foods. Critical Reviews in Toxicology 51:8, pages 695-722.
Read now
Read now
Amanda Hudson & Pamela Hudson. (2021) Risk Factors for Cannabis-Related Mental Health Harms in Older Adults: A Review. Clinical Gerontologist 44:1, pages 3-15.
Read now
Read now
Bhushan M. Kapur & Katarina Aleksa. (2020) What the lab can and cannot do: clinical interpretation of drug testing results. Critical Reviews in Clinical Laboratory Sciences 57:8, pages 548-585.
Read now
Read now
Peter S. Cogan. (2020) The ‘entourage effect’ or ‘hodge-podge hashish’: the questionable rebranding, marketing, and expectations of cannabis polypharmacy. Expert Review of Clinical Pharmacology 13:8, pages 835-845.
Read now
Read now
Yara Dadalti Fragoso, Adriana Carra & Miguel Angel Macias. (2020) Cannabis and multiple sclerosis. Expert Review of Neurotherapeutics 20:8, pages 849-854.
Read now
Read now
Kodye L. Abbott, Patrick C. Flannery, Kristina S. Gill, Dawn M. Boothe, Muralikrishnan Dhanasekaran, Sridhar Mani & Satyanarayana R. Pondugula. (2020) Adverse pharmacokinetic interactions between illicit substances and clinical drugs. Drug Metabolism Reviews 52:1, pages 44-65.
Read now
Read now
Peter S. Cogan. (2019) On healthcare by popular appeal: critical assessment of benefit and risk in cannabidiol based dietary supplements. Expert Review of Clinical Pharmacology 12:6, pages 501-511.
Read now
Read now
Catherine Chiron. (2019) Stiripentol for the treatment of seizures associated with Dravet syndrome. Expert Review of Neurotherapeutics 19:4, pages 301-310.
Read now
Read now
Epifanio Mondello¹, Domenico Quattrone, Luigi Cardia¹, Giuseppe Bova, Raffaella Mallamace¹, Alessia A Barbagallo, Cristina Mondello, Carmen Mannucci, Martina Di Pietro, Vincenzo Arcoraci & Gioacchino Calapai. (2018) Cannabinoids and spinal cord stimulation for the treatment of failed back surgery syndrome refractory pain. Journal of Pain Research 11, pages 1761-1767.
Read now
Read now
Carola Rong, Nicole E. Carmona, Yena L. Lee, Renee-Marie Ragguett, Zihang Pan, Joshua D. Rosenblat, Mehala Subramaniapillai, Margarita Shekotikhina, Fahad Almatham, Asem Alageel, Rodrigo Mansur, Roger C. Ho & Roger S. McIntyre. (2018) Drug-drug interactions as a result of co-administering Δ9-THC and CBD with other psychotropic agents. Expert Opinion on Drug Safety 17:1, pages 51-54.
Read now
Read now
Santosh Kumar, PSS Rao, Ravindra Earla & Anil Kumar. (2015) Drug–drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems. Expert Opinion on Drug Metabolism & Toxicology 11:3, pages 343-355.
Read now
Read now
Marjan de Vries, Dagmar CM van Rijckevorsel, Oliver HG Wilder-Smith & Harry van Goor. (2014) Dronabinol and chronic pain: importance of mechanistic considerations. Expert Opinion on Pharmacotherapy 15:11, pages 1525-1534.
Read now
Read now
Articles from other publishers (222)
Thomas Herdegen & Ingolf Cascorbi. (2023) Drug interactions of tetrahydrocannabinol and cannabidiol in cannabinoid drugs. Deutsches Ärzteblatt international.
Crossref
Crossref
T. Dixon & K. S. Cadenhead. (2023) Cannabidiol versus placebo as adjunctive treatment in early psychosis: study protocol for randomized controlled trial. Trials 24:1.
Crossref
Crossref
Hassan A. AlhassanHarriet Akunor, Ato HowardJoseph Donohue, Aleesha Kainat, Henry K. OnyeakaAryan Aiyer. (2023) Comparison of Atherosclerotic Cardiovascular Risk Factors and Cardiometabolic Profiles Between Current and Never Users of Marijuana. Circulation: Cardiovascular Quality and Outcomes 16:11.
Crossref
Crossref
Nina-Francecsa Parrella, Aron Thomas Hill, Peter Gregory Enticott, Pamela Barhoun, Isabella Simone Bower & Talitha Caitlyn Ford. (2023) A systematic review of cannabidiol trials in neurodevelopmental disorders. Pharmacology Biochemistry and Behavior, pages 173607.
Crossref
Crossref
Guillaume Fond, Tiffanie Muller, Marc Masson & Laurent Boyer. (2023) Cannabidiol (CBD) in psychiatric clinical practice: Current data. L'Encéphale 49:4, pages 329-330.
Crossref
Crossref
Tanja Dragun, Courtney V. Brown, Mikko P. Tulppo, Ante Obad & Željko Dujić. (2023) The Influence of Oral Cannabidiol on 24-h Ambulatory Blood Pressure and Arterial Stiffness in Untreated Hypertension: A Double-Blind, Placebo-Controlled, Cross-Over Pilot Study. Advances in Therapy 40:8, pages 3495-3511.
Crossref
Crossref
Federica Bianchi, Sophie Pautex, James Wampfler, François Curtin, Youssef Daali, Jules Alexandre Desmeules & Barbara Broers. (2023) Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocol. Frontiers in Pain Research 4.
Crossref
Crossref
Sebastián Pino, Luis Espinoza, Carlos Jara-Gutiérrez, Joan Villena, Andrés F. Olea & Katy Díaz. (2023) Study of Cannabis Oils Obtained from Three Varieties of C. sativa and by Two Different Extraction Methods: Phytochemical Characterization and Biological Activities. Plants 12:9, pages 1772.
Crossref
Crossref
Roua A. Nouh, Ahmed Kamal & Anwar Abdelnaser. (2023) Cannabinoids and Multiple Sclerosis: A Critical Analysis of Therapeutic Potentials and Safety Concerns. Pharmaceutics 15:4, pages 1151.
Crossref
Crossref
Michał Szulc, Radosław Kujawski, Amanda Pacholak, Marta Poprawska, Kamila Czora-Poczwardowska, Bogna Geppert & Przemysław Ł. Mikołajczak. (2023) Cannabidiol as a Modulator of the Development of Alcohol Tolerance in Rats. Nutrients 15:7, pages 1702.
Crossref
Crossref
Ilaria Ammendolia, Carmen Mannucci, Luigi Cardia, Gioacchino Calapai, Sebastiano Gangemi, Emanuela Esposito & Fabrizio Calapai. (2023) Pharmacovigilance on cannabidiol as an antiepileptic agent. Frontiers in Pharmacology 14.
Crossref
Crossref
Stefano Martini, Alessandra Gemma, Marco Ferrari, Marco Cosentino & Franca Marino. (2023) Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance. International Journal of Molecular Sciences 24:4, pages 3125.
Crossref
Crossref
Beatrice Marchetti, Sabrine Bilel, Micaela Tirri, Raffaella Arfè, Giorgia Corli, Elisa Roda, Carlo Alessandro Locatelli, Elena Cavarretta, Fabio De Giorgio & Matteo Marti. (2023) The Old and the New: Cardiovascular and Respiratory Alterations Induced by Acute JWH-018 Administration Compared to Δ9-THC—A Preclinical Study in Mice. International Journal of Molecular Sciences 24:2, pages 1631.
Crossref
Crossref
Fan Jiang, Ping Wu & Wei Zhang. (2023)
Synthesis and Biological Evaluation of 3′,5′‐d
2
‐Cannabidiol
. ChemistrySelect 8:1.
Crossref
Crossref
C. Espinosa-Jovel. (2023) Cannabinoids in epilepsy: clinical efficacy and pharmacological considerations. Neurología (English Edition) 38:1, pages 47-53.
Crossref
Crossref
C. Espinosa-Jovel. (2023) Cannabinoides en epilepsia: eficacia clínica y aspectos farmacológicos. Neurología 38:1, pages 49-55.
Crossref
Crossref
Sidarth Wakhlu, Mattie Steib, Peyton W. Moore, Warner Moore, Alexis L. Angelette, Elyse M. Cornett & Alan David Kaye. 2023. Substance Use and Addiction Research. Substance Use and Addiction Research
323
332
.
Ralph-Sydney Mboumba Bouassa, Judy Needham, Dana Nohynek, Joel Singer, Terry Lee, Florian Bobeuf, Suzanne Samarani, Lina Del Balso, Natalie Paisible, Claude Vertzagias, Giada Sebastiani, Shari Margolese, Enrico Mandarino, Marina Klein, Bertrand Lebouché, Joseph Cox, Marie-Josée Brouillette, Jean-Pierre Routy, Jason Szabo, Réjean Thomas, Emmanuel Huchet, Antonio Vigano, Mohammad-Ali Jenabian & Cecilia T Costiniuk. (2022) Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028). Biomedicines 10:12, pages 3168.
Crossref
Crossref
Alexa Torrens, Pritam RoyLin LinCindy VuDakota GrimesVictoria C. InshishianJohanna S. MontesinosFaizy AhmedStephen V. MahlerMarylin A. HuestisAditi DasDaniele Piomelli. (2022)
Comparative Pharmacokinetics of Δ
9
-Tetrahydrocannabinol in Adolescent and Adult Male and Female Rats
. Cannabis and Cannabinoid Research 7:6, pages 814-826.
Crossref
Crossref
David A. Campos, Edgar J. Mendivil, Mario Romano, Mariano García & Miriam E. Martínez. (2022) A Systematic Review of Medical Cannabinoids Dosing in Human. Clinical Therapeutics 44:12, pages e39-e58.
Crossref
Crossref
Michael C. Smith, Pavel Klein, Gregory L. Krauss, Samiya Rashid, Lawrence G. Seiden, John M. Stern & William E. Rosenfeld. (2022) Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations. Neurology and Therapy 11:4, pages 1705-1720.
Crossref
Crossref
Qianru Rao, Ting Zhang, Manyun Dai, Bin Li, Qianlun Pu, Min Zhao, Yan Cheng, Dongmei Yan, Qi Zhao, Zhanxuan E. Wu & Fei Li. (2022) Comparative Metabolomic Profiling of the Metabolic Differences of Δ9-Tetrahydrocannabinol and Cannabidiol. Molecules 27:21, pages 7573.
Crossref
Crossref
Catharine A. Mielnik, Chun Kit LiAmy J. RamseyAli SalahpourWillets McIntyre BurnhamRuth A. Ross. (2022) Cannabidiol, but Not Δ9-Tetrahydrocannabinol, Has Strain- and Genotype-Specific Effects in Models of Psychosis. Cannabis and Cannabinoid Research.
Crossref
Crossref
Markus Dieterle, Laura Zurbriggen, Eckhard Mauermann, Katja Mercer-Chalmers-Bender, Priska Frei, Wilhelm Ruppen & Tobias Schneider. (2022) Pain response to cannabidiol in opioid-induced hyperalgesia, acute nociceptive pain, and allodynia using a model mimicking acute pain in healthy adults in a randomized trial (CANAB II). Pain 163:10, pages 1919-1928.
Crossref
Crossref
Sophie Pautex, Federica Bianchi, Youssef Daali, Marc Augsburger, Christian de Saussure, James Wampfler, François Curtin, Jules Desmeules & Barbara Broers. (2022) Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
L Landa, V Trojan, R Demlova, J Jurica & R Hrib. (2022) Cannabidiol and the possibilities of its use in veterinary medicine of dogs and horses: A brief review. Veterinární medicína 67:9, pages 455-462.
Crossref
Crossref
Ralph-Sydney Mboumba Bouassa, Giada Sebastiani, Vincenzo Di Marzo, Mohammad-Ali Jenabian & Cecilia T. Costiniuk. (2022) Cannabinoids and Chronic Liver Diseases. International Journal of Molecular Sciences 23:16, pages 9423.
Crossref
Crossref
Gabriel A. Garcia, Stephanie Kube, Sheila Carrera-Justiz, David Tittle & Joseph J. Wakshlag. (2022) Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs. Frontiers in Veterinary Science 9.
Crossref
Crossref
Wujood Khayat & Christian Lehmann. (2022) The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies. Metabolites 12:6, pages 541.
Crossref
Crossref
Shilpi Goenka. (2022) Comparative Study of Δ9-Tetrahydrocannabinol and Cannabidiol on Melanogenesis in Human Epidermal Melanocytes from Different Pigmentation Phototypes: A Pilot Study. Journal of Xenobiotics 12:2, pages 131-144.
Crossref
Crossref
Lyndsey L. AndersonMaia G. EtchartLaura MacNairM. Hunter LandIrina A. MosesovaMarcel O. Bonn-MillerJonathon C. Arnold. (2022)
In Vitro
Screening of Three Commercial Cannabis-Based Products on ATP-Binding Cassette and Solute-Carrier Transporter Function
. Cannabis and Cannabinoid Research 7:3, pages 304-317.
Crossref
Crossref
Antoine Boden. (2022) Cannabis thérapeutique : prise en charge de la douleur et autres symptômes du cancer. Douleurs : Évaluation - Diagnostic - Traitement 23:3, pages 144-150.
Crossref
Crossref
Parthena Martin, Maciej Czerwiński, Pallavi B. Limaye, Brian W. Ogilvie, Steven Smith & Brooks Boyd. (2022) In vitro evaluation suggests fenfluramine and norfenfluramine are unlikely to act as perpetrators of drug interactions. Pharmacology Research & Perspectives 10:3.
Crossref
Crossref
Nibha Jain & Arumugam Moorthy. (2022) Cannabinoids in rheumatology: Friend, foe or a bystander?. Musculoskeletal Care 20:2, pages 416-428.
Crossref
Crossref
Ammaar H. Abidi, Sahar S. Alghamdi & Karen Derefinko. (2022) A critical review of cannabis in medicine and dentistry: A look back and the path forward. Clinical and Experimental Dental Research 8:3, pages 613-631.
Crossref
Crossref
Jonathan H. Aebischer, Nathan F. Dieckmann, Kim D. Jones & Amanda W. St John. (2022) Chronic Pain Clinical and Prescriptive Practices in the Cannabis Era. Pain Management Nursing 23:2, pages 109-121.
Crossref
Crossref
Amir Minerbi & Tali Sahar. 2022. Clinical Pain Management. Clinical Pain Management
206
217
.
V Vaissier Welborn. (2022) Beyond structural analysis of molecular enzyme-inhibitor interactions. Electronic Structure 4:1, pages 014006.
Crossref
Crossref
Valentina Lopera, Adriana Rodríguez & Pedro Amariles. (2022) Clinical Relevance of Drug Interactions with Cannabis: A Systematic Review. Journal of Clinical Medicine 11:5, pages 1154.
Crossref
Crossref
Felix Zhou, Andreu F Costa & Magnus McLeod. (2022) Late presentation of posterior reversible encephalopathy syndrome following liver transplantation in the setting of tacrolimus and cannabis use. Canadian Liver Journal 5:1, pages 91-95.
Crossref
Crossref
Anna E. Kirkland, Matthew C. Fadus, Staci A. Gruber, Kevin M. Gray, Timothy E. Wilens & Lindsay M. Squeglia. (2022) A scoping review of the use of cannabidiol in psychiatric disorders. Psychiatry Research 308, pages 114347.
Crossref
Crossref
Krzysztof Laudanski & Justin Wain. (2022) Considerations for Cannabinoids in Perioperative Care by Anesthesiologists. Journal of Clinical Medicine 11:3, pages 558.
Crossref
Crossref
Joshua Radke, Kelly Tocki & Brett A. Faine. (2022) A Review of the Metabolism and Potential Drug-drug Interactions With Addictive Drugs. Journal of Addiction Medicine 16:1, pages e30-e39.
Crossref
Crossref
Nicholas T. Lappas & Courtney M. Lappas. 2022. Forensic Toxicology. Forensic Toxicology
45
71
.
Stephanie Pieper. 2022. Pädiatrische Palliativversorgung – Schmerzbehandlung und Symptomkontrolle. Pädiatrische Palliativversorgung – Schmerzbehandlung und Symptomkontrolle
381
391
.
Jorge Luis Sotelo & Melanie Bilbul. 2022. Transplant Psychiatry. Transplant Psychiatry
167
176
.
Gregory L. Smith. 2022. Cannabis Use in Medicine. Cannabis Use in Medicine
133
142
.
Gerald Scott Winder & Erin G. Clifton. 2022. Cannabis in Psychiatric Practice. Cannabis in Psychiatric Practice
191
205
.
M. M. Dziwenka & R. W. Coppock. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
1353
1368
.
Claude Cyr, Mellar P. Davis, Danial Schecter & Paul DaeninckMellar P. Davis. 2022. Cannabis and Cannabinoid-Based Medicines in Cancer Care. Cannabis and Cannabinoid-Based Medicines in Cancer Care
41
89
.
M. M. Dziwenka & R. W. Coppock. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
1
17
.
Lyndsey L. Anderson, Marika Heblinski, Nathan L. Absalom, Nicole A. Hawkins, Michael T. Bowen, Melissa J. Benson, Fan Zhang, Dilara Bahceci, Peter T. Doohan, Mary Chebib, Iain S. McGregor, Jennifer A. Kearney & Jonathon C. Arnold. (2021) Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy. British Journal of Pharmacology 178:24, pages 4826-4841.
Crossref
Crossref
Xin Chen, Jashvant D. Unadkat & Qingcheng Mao. (2021) Tetrahydrocannabinol and Its Major Metabolites Are Not (or Are Poor) Substrates or Inhibitors of Human P-Glycoprotein [ATP-Binding Cassette (ABC) B1] and Breast Cancer Resistance Protein (ABCG2). Drug Metabolism and Disposition 49:10, pages 910-918.
Crossref
Crossref
Hannah C. Huff, Archit Vasan, Pritam Roy, Aayush Kaul, Emad Tajkhorshid & Aditi Das. (2021) Differential Interactions of Selected Phytocannabinoids with Human CYP2D6 Polymorphisms. Biochemistry 60:37, pages 2749-2760.
Crossref
Crossref
Lyndsey L. Anderson, Peter T. Doohan, Lachlan Oldfield, Richard C. Kevin, Jonathon C. Arnold, Maximus Berger, G. Paul Amminger & Iain S. McGregor. (2021) Citalopram and Cannabidiol. Journal of Clinical Psychopharmacology 41:5, pages 525-533.
Crossref
Crossref
Jamie F. Burr, Christian P. Cheung, Andreas M. Kasper, Scott H. Gillham & Graeme L. Close. (2021) Cannabis and Athletic Performance. Sports Medicine 51:S1, pages 75-87.
Crossref
Crossref
Fatma E. El‐Khouly, Syed M. Adil, Maria Wiese, Esther Hulleman, N. Harry Hendrikse, Gertjan J.L. Kaspers, Christof M. Kramm, Sophie E.M. Veldhuijzen van Zanten & Dannis G. van Vuurden. (2021) Complementary and alternative medicine in children with diffuse intrinsic pontine glioma—A SIOPE DIPG Network and Registry study. Pediatric Blood & Cancer 68:9.
Crossref
Crossref
Viktoriia Cherkasova, Olga Kovalchuk & Igor Kovalchuk. (2021) Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer. Cancers 13:17, pages 4353.
Crossref
Crossref
Daniel Rojas-Valverde. (2021) Potential Role of Cannabidiol on Sports Recovery: A Narrative Review. Frontiers in Physiology 12.
Crossref
Crossref
Ellen W. Leen-Feldner, Teah-Marie Bynion, Riley Gournay, Marcel O. Bonn-Miller & Matthew T. Feldner. (2021) Practical considerations for testing the effects of cannabidiol on human anxiety. Journal of Anxiety Disorders 82, pages 102429.
Crossref
Crossref
Christopher Vierke, Brigitte Marxen, Michael Boettcher, Christoph Hiemke & Ursula Havemann-Reinecke. (2020) Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy. European Archives of Psychiatry and Clinical Neuroscience 271:5, pages 847-856.
Crossref
Crossref
Lauren C. Smith, Lani Tieu, Raymond T. Suhandynata, Brent Boomhower, Melissa Hoffman, Yadira Sepulveda, Lieselot L. G. Carrette, Jeremiah D. Momper, Robert L. Fitzgerald, Kate Hanham, Joseph Dowling, Marsida Kallupi & Olivier George. (2021) Cannabidiol reduces withdrawal symptoms in nicotine-dependent rats. Psychopharmacology 238:8, pages 2201-2211.
Crossref
Crossref
Bryan Latrell Holloman, Mitzi Nagarkatti & Prakash Nagarkatti. (2021) Epigenetic Regulation of Cannabinoid-Mediated Attenuation of Inflammation and Its Impact on the Use of Cannabinoids to Treat Autoimmune Diseases. International Journal of Molecular Sciences 22:14, pages 7302.
Crossref
Crossref
Natasha E. Wade, Rachel Baca, Kelly E. Courtney, Connor J. McCabe, M. Alejandra Infante, Marilyn A. Huestis & Joanna Jacobus. (2021) Preliminary Evidence for Cannabis and Nicotine Urinary Metabolites as Predictors of Verbal Memory Performance and Learning Among Young Adults. Journal of the International Neuropsychological Society 27:6, pages 546-558.
Crossref
Crossref
Devendra Kumar & Neerja Trivedi. (2021) Disease-drug and drug-drug interaction in COVID-19: Risk and assessment. Biomedicine & Pharmacotherapy 139, pages 111642.
Crossref
Crossref
Alexander Starr, Kelly L. Jordan-Sciutto & Eugene Mironets. (2021) Confound, Cause, or Cure: The Effect of Cannabinoids on HIV-Associated Neurological Sequelae. Viruses 13:7, pages 1242.
Crossref
Crossref
Alessia Furgiuele, Marco Cosentino, Marco Ferrari & Franca Marino. (2021) Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review. Journal of Neuroimmune Pharmacology 16:2, pages 251-269.
Crossref
Crossref
Raymond G. Mattes, Melchor L. Espinosa, Sam S. Oh, Elizabeth M. Anatrella & Elizabeth M. Urteaga. (2021) Cannabidiol (CBD) Use in Type 2 Diabetes: A Case Report. Diabetes Spectrum 34:2, pages 198-201.
Crossref
Crossref
Haley V. Solomon, Aaron P. Greenstein & Lynn E. DeLisi. (2021) Cannabis Use in Older Adults: A Perspective. Harvard Review of Psychiatry 29:3, pages 225-233.
Crossref
Crossref
Henry L. Blanton, Robert C. Barnes, Melissa C. McHann, Joshua A. Bilbrey, Jenny L. Wilkerson & Josée Guindon. (2021) Sex differences and the endocannabinoid system in pain. Pharmacology Biochemistry and Behavior 202, pages 173107.
Crossref
Crossref
Vera Lukić, Ružica Micić, Biljana Arsić, Bojan Nedović & Živana Radosavljević. (2021) Overview of the major classes of new psychoactive substances, psychoactive effects, analytical determination and conformational analysis of selected illegal drugs. Open Chemistry 19:1, pages 60-106.
Crossref
Crossref
Pratibha Malhotra, Ilaria Casari & Marco Falasca. (2021) Therapeutic potential of cannabinoids in combination cancer therapy. Advances in Biological Regulation 79, pages 100774.
Crossref
Crossref
Karim S. Ladha, Alexander McLaren-Blades, Akash Goel, Michael J. Buys, Paul Farquhar-Smith, Simon Haroutounian, Yuvaraj Kotteeswaran, Kwesi Kwofie, Bernard Le Foll, Nicholas J. Lightfoot, Joel Loiselle, Hamish Mace, Judith Nicholls, Aviva Regev, Leiv Arne Rosseland, Harsha Shanthanna, Avinash Sinha, Ainsley Sutherland, Rob Tanguay, Sherry Yafai, Martha Glenny, Paul Choi, Salima S.J. Ladak, Timothy Sean Leroux, Ian Kawpeng, Bana Samman, Rajbir Singh & Hance Clarke. (2021) Perioperative Pain and Addiction Interdisciplinary Network (PAIN): consensus recommendations for perioperative management of cannabis and cannabinoid-based medicine users by a modified Delphi process. British Journal of Anaesthesia 126:1, pages 304-318.
Crossref
Crossref
Andreas M. Papas. 2021. Nutraceuticals. Nutraceuticals
991
1010
.
Andrew Charrette, James Akingbasote, Najla Guthrie & Corey J. Hilmas. 2021. Nutraceuticals. Nutraceuticals
625
659
.
Stevie C. Britch, Shanna Babalonis & Sharon L. Walsh. (2020) Cannabidiol: pharmacology and therapeutic targets. Psychopharmacology 238:1, pages 9-28.
Crossref
Crossref
Kylie O'Brien & Philip BlairKylie O’Brien & Philip Blair. 2021. Medicinal Cannabis and CBD in Mental Healthcare. Medicinal Cannabis and CBD in Mental Healthcare
513
557
.
Matthew Chung, Barlas Benkli, Salman Hirani & Christina Le-Short. 2021. Cannabinoids and Pain. Cannabinoids and Pain
211
220
.
George Polson, Matthew Chung, Salman Hirani & Christina Le-Short. 2021. Cannabinoids and Pain. Cannabinoids and Pain
93
101
.
Greg Copas, Erik Amazonas & Sarah Brandon. 2021. Cannabis Therapy in Veterinary Medicine. Cannabis Therapy in Veterinary Medicine
17
59
.
Marta Vázquez, Carlos García-Carnelli, Cecilia Maldonado & Pietro Fagiolino. 2021. Cannabinoids and Sleep. Cannabinoids and Sleep
27
42
.
Paula Morales & Nadine Jagerovic. 2021. Cannabinoids and Sleep. Cannabinoids and Sleep
11
25
.
Nadja Walle, Frederike Nordmeier, Adrian A. Doerr, Benjamin Peters, Matthias W. Laschke, Michael D. Menger, Peter H. Schmidt, Markus R. Meyer & Nadine Schaefer. (2020)
Comparison of
in vitro
and
in vivo
models for the elucidation of metabolic patterns of 7‐azaindole‐derived synthetic cannabinoids exemplified using cumyl‐5F‐P7AICA
. Drug Testing and Analysis 13:1, pages 74-90.
Crossref
Crossref
Danielle McCartney, Melissa J. Benson, Ben Desbrow, Christopher Irwin, Anastasia Suraev & Iain S. McGregor. (2020) Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research. Sports Medicine - Open 6:1.
Crossref
Crossref
Michael J. Stephen, Jared Chowdhury, Luis Arzeno Tejada, Robert Zanni & Denis Hadjiliadis. (2020) Use of medical marijuana in cystic fibrosis patients. BMC Complementary Medicine and Therapies 20:1.
Crossref
Crossref
Kathryn M. Nelson, Jonathan Bisson, Gurpreet Singh, James G. Graham, Shao-Nong Chen, J. Brent Friesen, Jayme L. Dahlin, Matthias Niemitz, Michael A. Walters & Guido F. Pauli. (2020) The Essential Medicinal Chemistry of Cannabidiol (CBD). Journal of Medicinal Chemistry 63:21, pages 12137-12155.
Crossref
Crossref
John R. Richards. (2020) Mechanisms for the Risk of Acute Coronary Syndrome and Arrhythmia Associated With Phytogenic and Synthetic Cannabinoid Use. Journal of Cardiovascular Pharmacology and Therapeutics 25:6, pages 508-522.
Crossref
Crossref
Daniela Amaral Silva, David W. Pate, Robert D. Clark, Neal M. Davies, Ayman O.S. El-Kadi & Raimar Löbenberg. (2020) Phytocannabinoid drug-drug interactions and their clinical implications. Pharmacology & Therapeutics 215, pages 107621.
Crossref
Crossref
Emily M. Hawes, Cameron R. Lee, Dana E. Brackney, Tucker G. Ensley, Julie Kidd & Cristen Page. (2020) Cannabidiol Products: Review of the Regulatory and Clinical Considerations. The Journal for Nurse Practitioners 16:10, pages 747-755.
Crossref
Crossref
Josh Cortopassi. (2020) Warfarin dose adjustment required after cannabidiol initiation and titration. American Journal of Health-System Pharmacy 77:22, pages 1846-1851.
Crossref
Crossref
Steven James. 2020. A Clinician's Guide to Cannabinoid Science. A Clinician's Guide to Cannabinoid Science
13
26
.
Margarita Zhelyazkova, Bogdan Kirilov & Georgi Momekov. (2020) The pharmacological basis for application of cannabidiol in cancer chemotherapy. Pharmacia 67:4, pages 239-252.
Crossref
Crossref
Guilherme Diogo Silva, Felipe Borelli Del Guerra, Maira de Oliveira Lelis & Lécio Figueira Pinto. (2020) Cannabidiol in the Treatment of Epilepsy: A Focused Review of Evidence and Gaps. Frontiers in Neurology 11.
Crossref
Crossref
Ece Unal, Brigitte Anderson, Andrew Helber & John H. Marks. (2020) Cannabinoids. Journal of Clinical Gastroenterology 54:9, pages 769-788.
Crossref
Crossref
Ruba S. Darweesh, Tareq N. Khamis & Tamam El-Elimat. (2020) The effect of cannabidiol on the pharmacokinetics of carbamazepine in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 393:10, pages 1871-1886.
Crossref
Crossref
Kevan E. VanLandingham, Julie Crockett, Lesley Taylor & Gilmour Morrison. (2020) A Phase 2, Double‐Blind, Placebo‐Controlled Trial to Investigate Potential Drug‐Drug Interactions Between Cannabidiol and Clobazam. The Journal of Clinical Pharmacology 60:10, pages 1304-1313.
Crossref
Crossref
Lyndsey L. Anderson, Ivan K. Low, Iain S. McGregor & Jonathon C. Arnold. (2020)
Interactions between cannabidiol and Δ
9
‐tetrahydrocannabinol in modulating seizure susceptibility and survival in a mouse model of Dravet syndrome
. British Journal of Pharmacology 177:18, pages 4261-4274.
Crossref
Crossref
Luke Daniel Williamson, Peter Wong & Nicholas Manolios. (2020) The ha(r)sh‐drug interactions in rheumatology. International Journal of Rheumatic Diseases 23:9, pages 1258-1260.
Crossref
Crossref
Dennis J. Sholler, Lauren Schoene & Tory R. Spindle. (2020) Therapeutic Efficacy of Cannabidiol (CBD): a Review of the Evidence From Clinical Trials and Human Laboratory Studies. Current Addiction Reports 7:3, pages 405-412.
Crossref
Crossref
Nevenka Kopjar, Nino Fuchs, Irena Brčić Karačonji, Suzana Žunec, Anja Katić, Goran Kozina & Ana Lucić Vrdoljak. (2020) High Doses of Δ9-Tetrahydrocannabinol Might Impair Irinotecan Chemotherapy: A Review of Potentially Harmful Interactions. Clinical Drug Investigation 40:9, pages 775-787.
Crossref
Crossref
Paul T. Kocis & Kent E. Vrana. (2020) Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions. Medical Cannabis and Cannabinoids 3:1, pages 61-73.
Crossref
Crossref
Marta Vázquez, Natalia Guevara, Cecilia Maldonado, Paulo Cáceres Guido & Paula Schaiquevich. (2020) Potential Pharmacokinetic Drug-Drug Interactions between Cannabinoids and Drugs Used for Chronic Pain. BioMed Research International 2020, pages 1-9.
Crossref
Crossref
Brandon J. Opitz, Marissa L. Ostroff & Arin C. Whitman. (2019) The Potential Clinical Implications and Importance of Drug Interactions Between Anticancer Agents and Cannabidiol in Patients With Cancer. Journal of Pharmacy Practice 33:4, pages 506-512.
Crossref
Crossref
Geoffrey W. Brown, Terrance J. Bellnier, Maria Janda & Kyle Miskowitz. (2020) Δ-9-tetrahydrocannabinol dose increase leads to warfarin drug interaction and elevated INR. Journal of the American Pharmacists Association.
Crossref
Crossref
Hemkumar Pushparaj & Anuj Bhatia. (2020) Behavioural disturbance after intravenous ketamine infusion for treatment of refractory chronic pain. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 67:8, pages 1108-1109.
Crossref
Crossref
John A. Karas, Labell J. M. Wong, Olivia K. A. Paulin, Amna C. Mazeh, Maytham H. Hussein, Jian Li & Tony Velkov. (2020) The Antimicrobial Activity of Cannabinoids. Antibiotics 9:7, pages 406.
Crossref
Crossref
Jessica N LeClair, Kevin W Chamberlin, Jessica Clement & Lisa M Holle. (2019) Documentation of medical marijuana use in cancer patients. Journal of Oncology Pharmacy Practice 26:5, pages 1117-1127.
Crossref
Crossref
Alexa Torrens, Valentina Vozella, Hannah Huff, Brandon McNeil, Faizy Ahmed, Andrea Ghidini, Stephen V. Mahler, Marilyn A. Huestis, Aditi Das & Daniele Piomelli. (2020)
Comparative Pharmacokinetics of Δ
9
-Tetrahydrocannabinol in Adolescent and Adult Male Mice
. Journal of Pharmacology and Experimental Therapeutics 374:1, pages 151-160.
Crossref
Crossref
Jack M. Hobbs, Allegra R. Vazquez, Nicholas D. Remijan, Roxanne E. Trotter, Thomas V. McMillan, Kimberly E. Freedman, Yuren Wei, Keith A. Woelfel, Olivia R. Arnold, Lisa M. Wolfe, Sarah A. Johnson & Tiffany L. Weir. (2020) Evaluation of pharmacokinetics and acute anti‐inflammatory potential of two oral cannabidiol preparations in healthy adults. Phytotherapy Research 34:7, pages 1696-1703.
Crossref
Crossref
Meir Bialer & Emilio Perucca. (2020) Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials. Epilepsia 61:6, pages 1082-1089.
Crossref
Crossref
Guy Hindley, Katherine Beck, Faith Borgan, Cedric E Ginestet, Robert McCutcheon, Daniel Kleinloog, Suhas Ganesh, Rajiv Radhakrishnan, Deepak Cyril D'Souza & Oliver D Howes. (2020) Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. The Lancet Psychiatry 7:4, pages 344-353.
Crossref
Crossref
Jessica Greger, Vernice Bates, Laszlo Mechtler & Fran Gengo. (2019) A Review of Cannabis and Interactions With Anticoagulant and Antiplatelet Agents. The Journal of Clinical Pharmacology 60:4, pages 432-438.
Crossref
Crossref
Sharon Chih, Michael McDonald, Anne Dipchand, Daniel Kim, Anique Ducharme, Annemarie Kaan, Susan Abbey, Mustafa Toma, Kim Anderson, Ryan Davey, Lisa Mielniczuk, Patricia Campbell, Shelley Zieroth, Christine Bourgault, Mitesh Badiwala, Brian Clarke, Eric Belanger, Michel Carrier, Jennifer Conway, Karen Doucette, Nadia Giannetti, Debra Isaac, Rod MacArthur & Mario Senechal. (2020) Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement on Heart Transplantation: Patient Eligibility, Selection, and Post-Transplantation Care. Canadian Journal of Cardiology 36:3, pages 335-356.
Crossref
Crossref
Michael D. Coleman. 2020. Human Drug Metabolism. Human Drug Metabolism
571
625
.
Sabrina Jones, Azure L. Yarbrough, William E. Fantegrossi, Paul L. Prather, John M. Bush, Anna Radominska‐Pandya & Ryoichi Fujiwara. (2020)
Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid
N
‐(adamantan‐1‐yl)‐1‐(5‐fluoropentyl)‐1
H
‐indole‐3‐carboxamide (STS‐135)
. Pharmacology Research & Perspectives 8:1.
Crossref
Crossref
Anmi Jose, Levin Thomas, Gayathri Baburaj, Murali Munisamy & Mahadev Rao. (2020) Cannabinoids as an alternative option for conventional analgesics in cancer pain management: A pharmacogenomics perspective. Indian Journal of Palliative Care 26:1, pages 129.
Crossref
Crossref
Chung Mo Koo, Se Hee Kim, Joon Soo Lee, Byung-Joo Park, Hae Kook Lee, Heung Dong Kim & Hoon-Chul Kang. (2020) Cannabidiol for Treating Lennox-Gastaut Syndrome and Dravet Syndrome in Korea. Journal of Korean Medical Science 35:50.
Crossref
Crossref
Kuntheavy Ing Lorenzini & François Girardin. (2019) Direct‐acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV‐infected patients. Liver International 40:1, pages 32-44.
Crossref
Crossref
Samira S. Farouk & Joshua L. Rein. (2020) The Many Faces of Calcineurin Inhibitor Toxicity—What the FK?. Advances in Chronic Kidney Disease 27:1, pages 56-66.
Crossref
Crossref
Jessica W. Skelley, Crystal M. Deas, Zachary Curren & Jonathan Ennis. (2020) Use of cannabidiol in anxiety and anxiety-related disorders. Journal of the American Pharmacists Association 60:1, pages 253-261.
Crossref
Crossref
Ersilia M. DeFilippis, Navkaranbir S. Bajaj, Amitoj Singh, Rhynn Malloy, Michael M. Givertz, Ron Blankstein, Deepak L. Bhatt & Muthiah Vaduganathan. (2020) Marijuana Use in Patients With Cardiovascular Disease. Journal of the American College of Cardiology 75:3, pages 320-332.
Crossref
Crossref
Karim S. LadhaVaruna ManooAli-Faizan VirjiJohn G. HanlonAlexander Mclaren-BladesAkash GoelDuminda N. WijeysunderaLakshmi P. KotraCarlos IbarraMarina EnglesakisHance Clarke. (2019) The Impact of Perioperative Cannabis Use: A Narrative Scoping Review. Cannabis and Cannabinoid Research 4:4, pages 219-230.
Crossref
Crossref
Brigitta Kis, Feng Chen Ifrim, Valentina Buda, Stefana Avram, Ioana Zinuca Pavel, Diana Antal, Virgil Paunescu, Cristina Adriana Dehelean, Florina Ardelean, Zorita Diaconeasa, Codruta Soica & Corina Danciu. (2019) Cannabidiol—from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer. International Journal of Molecular Sciences 20:23, pages 5905.
Crossref
Crossref
Ran Abuhasira, Addie Ron, Inbal Sikorin & Victor Novack. (2019) Medical Cannabis for Older Patients—Treatment Protocol and Initial Results. Journal of Clinical Medicine 8:11, pages 1819.
Crossref
Crossref
Daniel Moadel & Keira Chism. (2019) Medical Marijuana-Induced Tacrolimus Toxicity. Psychosomatics 60:6, pages 603-605.
Crossref
Crossref
Katarzyna Socała, Elżbieta Wyska, Małgorzata Szafarz, Dorota Nieoczym & Piotr Wlaź. (2019) Acute effect of cannabidiol on the activity of various novel antiepileptic drugs in the maximal electroshock- and 6 Hz-induced seizures in mice: Pharmacodynamic and pharmacokinetic studies. Neuropharmacology 158, pages 107733.
Crossref
Crossref
Brian C. Foster, Hanan Abramovici & Cory S. Harris. (2019) Cannabis and Cannabinoids: Kinetics and Interactions. The American Journal of Medicine 132:11, pages 1266-1270.
Crossref
Crossref
Andrew Penn. (2019) Cannabinoids and Mental Health, Part 2: The Search for Clinical Applications. Journal of Psychosocial Nursing and Mental Health Services 57:10, pages 7-11.
Crossref
Crossref
Kassandra R. Fabbri, Tracy L. Anderson‐Haag, Anne M. Spenningsby, Ajay Israni, Rachel M. Nygaard & Paul A. Stahler. (2019) Marijuana use should not preclude consideration for kidney transplantation. Clinical Transplantation 33:10.
Crossref
Crossref
Abbie D. Leino, Chie Emoto, Tsuyoshi Fukuda, Michael Privitera, Alexander A. Vinks & Rita R. Alloway. (2019) Evidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimus. American Journal of Transplantation 19:10, pages 2944-2948.
Crossref
Crossref
Randi von Wrede, Susanna Moskau-Hartmann, Nicola Amarell, Christian Erich Elger & Christoph Helmstaedter. (2019) Knowledge, expectations and fears of cannabis use of epilepsy patients at a tertiary epilepsy center. Epilepsy & Behavior 99, pages 106458.
Crossref
Crossref
Isaac Yao, Efrat Shavit Stein & Nicola Maggio. (2019) Cannabinoids, hippocampal excitability and efficacy for the treatment of epilepsy. Pharmacology & Therapeutics 202, pages 32-39.
Crossref
Crossref
Frank Petzke, Matthias Karst, Knud Gastmeier, Lukas Radbruch, Eva Steffen & Winfried Häuser. (2019) Ein Positionspapier zu medizinischem Cannabis und cannabisbasierten Medikamenten in der SchmerzmedizinPosition paper on medical cannabis and cannabis-based medicines in pain medicine. Der Schmerz 33:5, pages 449-465.
Crossref
Crossref
Yukako Nakano, Masataka Tajima, Erika Sugiyama, Vilasinee Hirunpanich Sato & Hitoshi Sato. (2019) Development of a Novel Nanoemulsion Formulation to Improve Intestinal Absorption of Cannabidiol. Medical Cannabis and Cannabinoids 2:1, pages 35-42.
Crossref
Crossref
S.A. Millar, N.L. Stone, Z.D. Bellman, A.S. Yates, T.J. England & S.E. O'Sullivan. (2019) A systematic review of cannabidiol dosing in clinical populations. British Journal of Clinical Pharmacology 85:9, pages 1888-1900.
Crossref
Crossref
Emily J. Cox, Neha Maharao, Gabriela Patilea-Vrana, Jashvant D. Unadkat, Allan E. Rettie, Jeannine S. McCune & Mary F. Paine. (2019) A marijuana-drug interaction primer: Precipitants, pharmacology, and pharmacokinetics. Pharmacology & Therapeutics 201, pages 25-38.
Crossref
Crossref
Harrison J. VanDolah, Brent A. Bauer & Karen F. Mauck. (2019) Clinicians’ Guide to Cannabidiol and Hemp Oils. Mayo Clinic Proceedings 94:9, pages 1840-1851.
Crossref
Crossref
Valentina Franco & Emilio Perucca. (2019) Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy. Drugs 79:13, pages 1435-1454.
Crossref
Crossref
Danielle Brown, Michael Watson & Janet Schloss. (2019) Pharmacological evidence of medicinal cannabis in oncology: a systematic review. Supportive Care in Cancer 27:9, pages 3195-3207.
Crossref
Crossref
Thomas R. Arkell, Nicholas Lintzeris, Richard C. Kevin, Johannes G. Ramaekers, Ryan Vandrey, Christopher Irwin, Paul S. Haber & Iain S. McGregor. (2019) Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition. Psychopharmacology 236:9, pages 2713-2724.
Crossref
Crossref
Julie Zhu & Kevork M Peltekian. (2019) Cannabis and the liver: Things you wanted to know but were afraid to ask. Canadian Liver Journal 2:3, pages 51-57.
Crossref
Crossref
Kerstin A. Klotz, Martin Hirsch, Marcel Heers, Andreas Schulze‐Bonhage & Julia Jacobs. (2019) Effects of cannabidiol on brivaracetam plasma levels. Epilepsia 60:7.
Crossref
Crossref
Jung H. Kim & Darryl Brown. (2019) Medical Marijuana and the Patient With Chronic Pain. Topics in Pain Management 34:12, pages 1-8.
Crossref
Crossref
Ditte Demontis, Veera Manikandan Rajagopal, Thorgeir E. Thorgeirsson, Thomas D. Als, Jakob Grove, Kalle Leppälä, Daniel F. Gudbjartsson, Jonatan Pallesen, Carsten Hjorthøj, Gunnar W. Reginsson, Thorarinn Tyrfingsson, Valgerdur Runarsdottir, Per Qvist, Jane Hvarregaard Christensen, Jonas Bybjerg-Grauholm, Marie Bækvad-Hansen, Laura M. Huckins, Eli A. Stahl, Allan Timmermann, Esben Agerbo, David M. Hougaard, Thomas Werge, Ole Mors, Preben Bo Mortensen, Merete Nordentoft, Mark J. Daly, Hreinn Stefansson, Kari Stefansson, Mette Nyegaard & Anders D. Børglum. (2019) Genome-wide association study implicates CHRNA2 in cannabis use disorder. Nature Neuroscience 22:7, pages 1066-1074.
Crossref
Crossref
Laura E. Ewing, Mitchell R. McGill, Eric U. Yee, Charles M. Quick, Charles M. Skinner, Stefanie Kennon-McGill, Melissa Clemens, Joel H. Vazquez, Sandra S. McCullough, D. Keith Williams, Kristy R. Kutanzi, Larry A. Walker, Mahmoud A. ElSohly, Laura P. James, Bill J. Gurley & Igor Koturbash. (2019) Paradoxical Patterns of Sinusoidal Obstruction Syndrome-Like Liver Injury in Aged Female CD-1 Mice Triggered by Cannabidiol-Rich Cannabis Extract and Acetaminophen Co-Administration. Molecules 24:12, pages 2256.
Crossref
Crossref
Jeffrey W. Chen, Laura M. Borgelt & Allison B. Blackmer. (2019) Cannabidiol: A New Hope for Patients With Dravet or Lennox-Gastaut Syndromes. Annals of Pharmacotherapy 53:6, pages 603-611.
Crossref
Crossref
Paula Morales & Nadine Jagerovic. (2019) Antitumor Cannabinoid Chemotypes: Structural Insights. Frontiers in Pharmacology 10.
Crossref
Crossref
Jane Alcorn, Stephanie Vuong, Fang Wu, Blair Seifert & Andrew Lyon. 2019. Recent Advances in Cannabinoid Research. Recent Advances in Cannabinoid Research.
Daniel Friedman, Jacqueline A French & Mauro Maccarrone. (2019) Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders. The Lancet Neurology 18:5, pages 504-512.
Crossref
Crossref
Danny Nemu. (2019) Getting high with the most high: Entheogens in the Old Testament. Journal of Psychedelic Studies 3:2, pages 117-132.
Crossref
Crossref
Gabriela I. Patilea-Vrana, Olena Anoshchenko & Jashvant D. Unadkat. (2019)
Hepatic Enzymes Relevant to the Disposition of (−)-∆
9
-Tetrahydrocannabinol (THC) and Its Psychoactive Metabolite, 11-OH-THC
. Drug Metabolism and Disposition 47:3, pages 249-256.
Crossref
Crossref
April Christensen & Jennifer Pruskowski. (2019) The Role of Cannabidiol in Palliative Care #370. Journal of Palliative Medicine 22:3, pages 337-338.
Crossref
Crossref
Maya R. Jacobson, Jeremy J. Watts, Isabelle Boileau, Junchao Tong & Romina Mizrahi. (2019) A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis. European Neuropsychopharmacology 29:3, pages 330-348.
Crossref
Crossref
Julia Sophie Schneider, Angela Gasse, Marianne Schürenkamp, Ursula Sibbing, Sabrina Banken, Heidi Pfeiffer, Jennifer Schürenkamp & Marielle Vennemann. (2018) Multiplex analysis of genetic polymorphisms within UGT1A9, a gene involved in phase II of Δ9-THC metabolism. International Journal of Legal Medicine 133:2, pages 365-372.
Crossref
Crossref
Marilyn E. Levi, Brian T. Montague, Christian Thurstone, Deepali Kumar, Shirish S. Huprikar & Camille N. Kotton. (2019) Marijuana use in transplantation: A call for clarity. Clinical Transplantation 33:2, pages e13456.
Crossref
Crossref
Catherine Dong, Jingwen Chen, Amy Harrington, K. Yaragudri Vinod, Muralidhar L. Hegde & Venkatesh L. Hegde. (2018) Cannabinoid exposure during pregnancy and its impact on immune function. Cellular and Molecular Life Sciences 76:4, pages 729-743.
Crossref
Crossref
Dana Barchel, Orit Stolar, Tal De-Haan, Tomer Ziv-Baran, Naama Saban, Danny Or Fuchs, Gideon Koren & Matitiahu Berkovitch. (2019) Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities. Frontiers in Pharmacology 9.
Crossref
Crossref
Marcin Kopka. (2019) Cannabinoids in the treatment of epilepsy – an updated review. Journal of Epileptology 27, pages 35-42.
Crossref
Crossref
Claudia Ho, Dan Martinusen & Clifford Lo. (2019) A Review of Cannabis in Chronic Kidney Disease Symptom Management. Canadian Journal of Kidney Health and Disease 6, pages 205435811982839.
Crossref
Crossref
Cathy Davies & Sagnik Bhattacharyya. (2019) Cannabidiol as a potential treatment for psychosis. Therapeutic Advances in Psychopharmacology 9, pages 204512531988191.
Crossref
Crossref
Per Damkier, Dorte Lassen, Mette Marie Hougaard Christensen, Kenneth Grønkjaer Madsen, Maja Hellfritzsch & Anton Pottegård. (2019) Interaction between warfarin and cannabis. Basic & Clinical Pharmacology & Toxicology 124:1, pages 28-31.
Crossref
Crossref
Muhammad Alsherbiny & Chun Li. (2018) Medicinal Cannabis—Potential Drug Interactions. Medicines 6:1, pages 3.
Crossref
Crossref
Allison Karst. (2018) Weighing the Benefits and Risks of Medical Marijuana Use: A Brief Review. Pharmacy 6:4, pages 128.
Crossref
Crossref
Matthew King & Nauman Ashraf. (2018) Tricyclic Antidepressant-Induced Anticholinergic Delirium in a Young Healthy Male Individual. Drug Safety - Case Reports 5:1.
Crossref
Crossref
Sophie A. Millar, Nicole L. Stone, Andrew S. Yates & Saoirse E. O'Sullivan. (2018) A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans. Frontiers in Pharmacology 9.
Crossref
Crossref
Holger Petri. (2018) Arzneimitteltherapiesicherheit: Das Interaktionspotenzial der Cannabinoide. Deutsches Ärzteblatt Online.
Crossref
Crossref
Lesley Taylor, Barry Gidal, Graham Blakey, Bola Tayo & Gilmour Morrison. (2018) A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects. CNS Drugs 32:11, pages 1053-1067.
Crossref
Crossref
Régis Bouquié, Guillaume Deslandes, Hélène Mazaré, Marion Cogné, Julien Mahé, Matthieu Grégoire & Pascale Jolliet. (2018) Cannabis and anticancer drugs: societal usage and expected pharmacological interactions - a review. Fundamental & Clinical Pharmacology 32:5, pages 462-484.
Crossref
Crossref
Winfried Häuser, David P. Finn, Eija Kalso, Nevenka Krcevski-Skvarc, Hans-Georg Kress, Bart Morlion, Serge Perrot, Michael Schäfer, Chris Wells & Silviu Brill. (2018) European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management. European Journal of Pain 22:9, pages 1547-1564.
Crossref
Crossref
Mary Amanda Dew, Andrea F. DiMartini, Fabienne Dobbels, Kathleen L. Grady, Sheila G. Jowsey-Gregoire, Annemarie Kaan, Kay Kendall, Quincy-Robyn Young, Susan E. Abbey, Zeeshan Butt, Catherine C. Crone, Sabina De Geest, Christina T. Doligalski, Christiane Kugler, Laurie McDonald, Linda Ohler, Liz Painter, Michael G. Petty, Desiree Robson, Thomas Schlöglhofer, Terry D. Schneekloth, Jonathan P. Singer, Patrick J. Smith, Heike Spaderna, Jeffrey J. Teuteberg, Roger D. Yusen & Paula C. Zimbrean. (2018) The 2018 ISHLT/APM/AST/ICCAC/STSW Recommendations for the Psychosocial Evaluation of Adult Cardiothoracic Transplant Candidates and Candidates for Long-term Mechanical Circulatory Support. Psychosomatics 59:5, pages 415-440.
Crossref
Crossref
Paul E. Sanmartin & Kamil Detyniecki. (2018) Cannabidiol for Epilepsy: New Hope on the Horizon?. Clinical Therapeutics 40:9, pages 1438-1441.
Crossref
Crossref
Catherine J. Lucas, Peter Galettis, Shuzhen Song, Nadia Solowij, Stephanie E. Reuter, Jennifer Schneider & Jennifer H. Martin. (2018) Cannabinoid Disposition After Human Intraperitoneal Use: An Insight Into Intraperitoneal Pharmacokinetic Properties in Metastatic Cancer. Clinical Therapeutics 40:9, pages 1442-1447.
Crossref
Crossref
John C. AchenbachJessica HillJoseph P.M. HuiMichael G. MorashFabrice BerrueLee D. Ellis. (2018) Analysis of the Uptake, Metabolism, and Behavioral Effects of Cannabinoids on Zebrafish Larvae. Zebrafish 15:4, pages 349-360.
Crossref
Crossref
Daphna Katz-Talmor, Itay Katz, Bat-Sheva Porat-Katz & Yehuda Shoenfeld. (2018) Cannabinoids for the treatment of rheumatic diseases — where do we stand?. Nature Reviews Rheumatology 14:8, pages 488-498.
Crossref
Crossref
Edward J. Hoffenberg, Shannon K. McWilliams, Susan K. Mikulich-Gilbertson, Brittany V. Murphy, Megan Lagueux, Kristen Robbins, Analice S. Hoffenberg, Edwin de Zoeten & Christian J. Hopfer. (2018) Marijuana Use by Adolescents and Young Adults with Inflammatory Bowel Disease. The Journal of Pediatrics 199, pages 99-105.
Crossref
Crossref
Mary Amanda Dew, Andrea F. DiMartini, Fabienne Dobbels, Kathleen L. Grady, Sheila G. Jowsey-Gregoire, Annemarie Kaan, Kay Kendall, Quincy-Robyn Young, Susan E. Abbey, Zeeshan Butt, Catherine C. Crone, Sabina De Geest, Christina T. Doligalski, Christiane Kugler, Laurie McDonald, Linda Ohler, Liz Painter, Michael G. Petty, Desiree Robson, Thomas Schlöglhofer, Terry D. Schneekloth, Jonathan P. Singer, Patrick J. Smith, Heike Spaderna, Jeffrey J. Teuteberg, Roger D. Yusen & Paula C. Zimbrean. (2018) The 2018 ISHLT/APM/AST/ICCAC/STSW recommendations for the psychosocial evaluation of adult cardiothoracic transplant candidates and candidates for long-term mechanical circulatory support. The Journal of Heart and Lung Transplantation 37:7, pages 803-823.
Crossref
Crossref
. (2018) Appendix C: References (Part I). Journal of Nursing Regulation 9:2, pages S52-S58.
Crossref
Crossref
. (2018) Adverse Effects of Cannabis. Journal of Nursing Regulation 9:2, pages S14-S17.
Crossref
Crossref
. (2018) Part I: Current Legislation, Scientific Literature Review, and Nursing Implications. Journal of Nursing Regulation 9:2, pages S6-S21.
Crossref
Crossref
Steven Ivulich, Glen Westall, Michael Dooley & Gregory Snell. (2018) The Evolution of Lung Transplant Immunosuppression. Drugs 78:10, pages 965-982.
Crossref
Crossref
Tae Yeon Kong, Ju-Hyun Kim, Dong Kyun Kim & Hye Suk Lee. (2018) Synthetic cannabinoids are substrates and inhibitors of multiple drug-metabolizing enzymes. Archives of Pharmacal Research 41:7, pages 691-710.
Crossref
Crossref
Ana Lucić Vrdoljak, Nino Fuchs, Anja Mikolić, Suzana Žunec, Irena Brčić Karačonji, Andreja Jurič, Ljerka Prester, Vedran Micek, Marijana Neuberg, Samir Čanović, Gordan Mršić & Nevenka Kopjar. (2018) Irinotecan and Δ9-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers. Molecules 23:6, pages 1332.
Crossref
Crossref
Tae Kong, Soon-Sang Kwon, Jae Cheong, Hee Kim, Jin Kim & Hye Lee. (2018) In Vitro Inhibitory Effects of Synthetic Cannabinoid EAM-2201 on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes. Molecules 23:4, pages 920.
Crossref
Crossref
Orrin DevinskyAnup D. PatelElizabeth A. ThieleMatthew H. WongRichard AppletonCynthia L. HardenSam GreenwoodGilmour MorrisonKenneth SommervilleAngus Wilfong, Robert Flamini, Linda Laux, Ian Miller, Helen Cross, Charuta Joshi, Richard Chin & Sameer Zuberi. (2018) Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome. Neurology 90:14.
Crossref
Crossref
Displaying 200 of 238 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list